‹ All Posts
Rakesh Kumar

18th Nov · SEBI-Registered Analyst

Wockhardt Results Analysis

WOCKPHARMA
Operating Revenue for Q2FY26 is Rs. 782 Cr., 3.34% Negative growth YoY, Total Income is Rs. 803 Cr., 1.83% Negative growth YoY, EBITDA is Rs. 178 Cr., 61.82% growth YoY, EBITDA Margin is 22.76% improved by 917 Basis points YoY, PBT Rs. 91 Cr. turned profitable from loss of Rs. 9 Cr. YoY, PAT Rs. 82 Cr., turned profitable from loss of Rs. 16 Cr. YoY. On QoQ basis Operating Revenue has 5.96% Growth, EBITDA is also grown by 147%, EBITDA Margin improved by 1301 Basis points, PBT and PAT turns profitable from loss is previous quarter.

#WatchOutFor#StockInNews#FundamentalViews#TrendingSectors#MacroViews
983 likes·52 comments